These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 16515959)
1. Prostate specific antigen and other markers for prostate cancer. Schröder FH J Urol; 2006 Apr; 175(4):1199-200. PubMed ID: 16515959 [No Abstract] [Full Text] [Related]
2. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed]. Bratt O; Björk T Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615 [No Abstract] [Full Text] [Related]
3. [Prostatic cancer--can unnecessary therapy be avoided? Prostate-specific antigens (PSA) kinetics can guide the management]. Malmström PU Lakartidningen; 2006 Feb 1-7; 103(5):279. PubMed ID: 16512565 [No Abstract] [Full Text] [Related]
4. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer]. Medvedev VL Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295 [No Abstract] [Full Text] [Related]
5. Establishment of a serum tumor marker for preclinical trials of mouse prostate cancer models. Huizen IV; Wu G; Moussa M; Chin JL; Fenster A; Lacefield JC; Sakai H; Greenberg NM; Xuan JW Clin Cancer Res; 2005 Nov; 11(21):7911-9. PubMed ID: 16278416 [TBL] [Abstract][Full Text] [Related]
6. [Prostatic specific antigen: role and significance in urologic practice]. Manolović D; Pejcić T; Milović N Srp Arh Celok Lek; 1994; 122(5-6):171-3. PubMed ID: 17977420 [TBL] [Abstract][Full Text] [Related]
7. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA? Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815 [TBL] [Abstract][Full Text] [Related]
8. [PSA based screening for prostatic cancer]. Johansen TE Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357 [No Abstract] [Full Text] [Related]
9. Prostate cancer detection: beware of the low PSA. Haas GP Can J Urol; 2007 Jun; 14(3):3534. PubMed ID: 17594742 [No Abstract] [Full Text] [Related]
10. Screening for prostate cancer in 2007: the PSA era and its challenges are not over. Shariat SF; Karakiewicz PI Eur Urol; 2008 Mar; 53(3):457-60. PubMed ID: 18079050 [No Abstract] [Full Text] [Related]
11. Prostate cancer: is the PSA test the answer? Berlin B N J Med; 1998 Mar; 95(3):53-5. PubMed ID: 16013148 [No Abstract] [Full Text] [Related]
12. [Based on current knowledge the introduction of the PSA screening for prostatic cancer is unethical]. Krantz I; Sachs L; Ahlberg BM; Nordin P; Nilstun T Lakartidningen; 2005 Sep 5-11; 102(36):2498-500. PubMed ID: 16196436 [No Abstract] [Full Text] [Related]
13. Application of prostate-specific antigen in prostate cancer. Liang SL MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558 [No Abstract] [Full Text] [Related]
14. [Prostate-specific antigen in early detection of prostate cancer]. Steurer J Dtsch Med Wochenschr; 1997 Apr; 122(16):529. PubMed ID: 9162629 [No Abstract] [Full Text] [Related]
16. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues. Ito K Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638 [No Abstract] [Full Text] [Related]
17. [The prostate specific antigen: what can we learn from the American experience?]. Zhao XJ Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833 [No Abstract] [Full Text] [Related]
18. [PSA--monitoring the prostate. Diagnostic series: Early detection of prostatic carcinoma]. Janssen K MMW Fortschr Med; 2000 Oct; 142(41):45. PubMed ID: 11085077 [No Abstract] [Full Text] [Related]
19. [Pro PSA: a new prostate cancer marker]. Peyromaure M Prog Urol; 2004 Sep; 14(4 Suppl):8-11. PubMed ID: 15776578 [No Abstract] [Full Text] [Related]